FDA Clearance Tracker · P140003-S111
Impella CP with SmartAssist, Impella 5.5 with SmartAssist
Last checked: Nov 20, 2026Latest source record: Dec 3, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Dec 3, 2024
Approved
Time to decision
613 days
Received Mar 31, 2023. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P140003-S111
- Device name
- Impella CP with SmartAssist, Impella 5.5 with SmartAssist
- Applicant
- Abiomed, Inc.
- Applicant location
- Danvers, MA
- Received
- Mar 31, 2023
- Decided
- Dec 3, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P140003
Device type
- Device class
- Class III
- Specialty
- Cardiology
FDA's approval statement
As written in FDA's record.
Approval for a labeling update regarding pediatric uses of the Impella CP with SmartAssist and Impella 5.5 with SmartAssist systems.
Source documents
Other decisions for Abiomed, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252766 · Decided Oct 8, 2025 · 40 days after receipt
Device type: Introducer, Catheter (DYB) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.